Clinical Trial: First-in-Human Clinical Trial of STUP-001, an In Vivo Direct Cell Conversion Gene Therapy for AIS-A/B Chronic Spinal Cord Injury

U.S., April 12 -- ClinicalTrials.gov registry received information related to the study (NCT06922890) titled 'First-in-Human Clinical Trial of STUP-001, an In Vivo Direct Cell Conversion Gene Therapy for AIS-A/B Chronic Spinal Cord Injury' on April 03.

Brief Summary: This study aim to investigate the safety and exploratory efficacy of STUP-001 which is AAV-based spinal cord injury investigational product.

Study Start Date: July 30, 2025

Study Type: INTERVENTIONAL

Condition: Spinal Cord Injury Chronic Spinal Cord Injury

Intervention: DRUG: STUP-001

in vivo direct cell conversion gene therapy investigational product

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Yonsei University

Information provided by (Responsible Party): Yoon H...